Literature DB >> 9356466

MAD2 associates with the cyclosome/anaphase-promoting complex and inhibits its activity.

Y Li1, C Gorbea, D Mahaffey, M Rechsteiner, R Benezra.   

Abstract

Cell cycle progression is monitored by checkpoint mechanisms that ensure faithful duplication and accurate segregation of the genome. Defects in spindle assembly or spindle-kinetochore attachment activate the mitotic checkpoint. Once activated, this checkpoint arrests cells prior to the metaphase-anaphase transition with unsegregated chromosomes, stable cyclin B, and elevated M phase promoting factor activity. However, the mechanisms underlying this process remain obscure. Here we report that upon activation of the mitotic checkpoint, MAD2, an essential component of the mitotic checkpoint, associates with the cyclin B-ubiquitin ligase, known as the cyclosome or anaphase-promoting complex. Moreover, purified MAD2 causes a metaphase arrest in cycling Xenopus laevis egg extracts and prevents cyclin B proteolysis by blocking its ubiquitination, indicating that MAD2 functions as an inhibitor of the cyclosome. Thus, MAD2 links the mitotic checkpoint pathway to the cyclin B destruction machinery which is critical in controlling the metaphase-anaphase transition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356466      PMCID: PMC24983          DOI: 10.1073/pnas.94.23.12431

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex.

Authors:  X He; T E Patterson; S Sazer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Make it or break it: the role of ubiquitin-dependent proteolysis in cellular regulation.

Authors:  R J Deshaies
Journal:  Trends Cell Biol       Date:  1995-11       Impact factor: 20.808

3.  The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase.

Authors:  M Brandeis; T Hunt
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

Review 4.  Cell cycle checkpoints: preventing an identity crisis.

Authors:  S J Elledge
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

5.  Spindle formation and chromatin condensation in cells blocked at interphase by mutation of a negative cell cycle control gene.

Authors:  S A Osmani; D B Engle; J H Doonan; N R Morris
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase.

Authors:  S Lahav-Baratz; V Sudakin; J V Ruderman; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

7.  A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.

Authors:  R W King; J M Peters; S Tugendreich; M Rolfe; P Hieter; M W Kirschner
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

8.  Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor.

Authors:  S L Holloway; M Glotzer; R W King; A W Murray
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

9.  TPR proteins required for anaphase progression mediate ubiquitination of mitotic B-type cyclins in yeast.

Authors:  W Zachariae; K Nasmyth
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

10.  Ubiquitin-lysozyme conjugates. Purification and susceptibility to proteolysis.

Authors:  R Hough; M Rechsteiner
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

View more
  78 in total

1.  Pds1p of budding yeast has dual roles: inhibition of anaphase initiation and regulation of mitotic exit.

Authors:  O Cohen-Fix; D Koshland
Journal:  Genes Dev       Date:  1999-08-01       Impact factor: 11.361

2.  Mitotic regulation of the APC activator proteins CDC20 and CDH1.

Authors:  E R Kramer; N Scheuringer; A V Podtelejnikov; M Mann; J M Peters
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

3.  Hypomorphic bimA(APC3) alleles cause errors in chromosome metabolism that activate the DNA damage checkpoint blocking cytokinesis in Aspergillus nidulans.

Authors:  T D Wolkow; P M Mirabito; S Venkatram; J E Hamer
Journal:  Genetics       Date:  2000-01       Impact factor: 4.562

4.  Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint.

Authors:  L Sironi; M Melixetian; M Faretta; E Prosperini; K Helin; A Musacchio
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

5.  Targeted new membrane addition in the cleavage furrow is a late, separate event in cytokinesis.

Authors:  C B Shuster; D R Burgess
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

6.  Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex.

Authors:  Guowei Fang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

7.  Pds1 phosphorylation in response to DNA damage is essential for its DNA damage checkpoint function.

Authors:  H Wang; D Liu; Y Wang; J Qin; S J Elledge
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

8.  Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint.

Authors:  Lucia Sironi; Marina Mapelli; Stefan Knapp; Anna De Antoni; Kuan-Teh Jeang; Andrea Musacchio
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

9.  Identification of a MAD2-binding protein, CMT2, and its role in mitosis.

Authors:  Toshiyuki Habu; Sang Hoon Kim; Jasminder Weinstein; Tomohiro Matsumoto
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

10.  Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension.

Authors:  Katie B Shannon; Julie C Canman; E D Salmon
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.